On October 16, 2024 Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, reported that the Company will be providing a corporate update at the upcoming investor conferences on the dates below (Press release, Soligenix, OCT 16, 2024, View Source [SID1234647231]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2024 Maxim Healthcare Virtual Summit, held October 17, 2024. For more information, please refer to the conference website https://m-vest.com/events/healthcare-10152024.

ThinkEquity Conference, held October 30, 2024. For more information, please refer to the conference website View Source

Spartan Capital Investor Conference 2024, held November 4, 2024. For more information, please refer to the conference website View Source
Key members of Soligenix management will hold one-on-one meetings throughout the conferences. If you are unable to attend the conferences and would like to schedule a meeting with management, please contact [email protected].